Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 14, 73-85
Abstract
Background: Antiretroviral therapy (ART) regimen failure is linked to an increased risk of disease progression and death, while early detection of ART failure can help to prevent the development of resistance. This study aimed to evaluate virological and immunological ART failure and predictors among HIV-positive adult and adolescent clients in southeast Ethiopia. Methods: A retrospective cohort study was implemented from January 2016 to November 30, 2020; all HIV-positive nave patients on follow-up during the study period from four hospitals were included. Virological and immunological treatment failure was the primary outcome of the study. Cox proportional hazards regression models were employed for analysis. Hazard ratios with 95% confidence intervals were reported and variables with p-values < 0.05 were considered statistically significant predictors of treatment failure. Results: A total of 641 HIV patients’ charts were reviewed, 62.6% of the study participants were females. Of the total study participants, 18.4% and 15% developed virological and immunological ART regimen treatment failure respectively. The median time to virological failure was 40 months. WHO stage IV [AHR = 4.616; 95% CI: (2.136– 9.974)], WHO stage III [AHR = 2.323; 95% CI: (1.317– 4.098)], poor adherence to HAART regimen [AHR = 3.097; 95% CI: (1.349– 7.108)], and fair adherence [AHR = 2.058; 95% CI: (1.234– 3.432)] were significantly associated with virological treatment failure among adolescent and adult study participants in southeast Ethiopia. Conclusion: The prevalence of virological treatment failure was 18.4% (95% CI: 15.4 − 21.4) and the prevalence of immunological treatment failure was 15% (95% CI: 11.8– 18.4). WHO clinical stage III/IV and non-adherence were independent predictors of virological ART treatment failure. Early management of clinical WHO stages and improving patients’ ART regimen adherence are important to decrease the prevalence of ART regimen treatment failure.Keywords
This publication has 46 references indexed in Scilit:
- Immunological failure of first‐line and switch to second‐line antiretroviral therapy among HIV‐infected persons in Tanzania: analysis of routinely collected national dataTropical Medicine & International Health, 2015
- Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provincesSexually Transmitted Infections, 2014
- Predicting treatment failure in adults and children on antiretroviral therapyAIDS, 2014
- Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in MozambiquePLOS ONE, 2013
- Factores asociados a falla virológica en pacientes infectados con VIH que reciben terapia anti-retroviral en un hospital público del PerúRevista chilena de infectología, 2013
- Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, KenyaPLOS ONE, 2012
- Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited SettingsClinical Infectious Diseases, 2011
- The pattern of immunologic and virologic responses to Highly Active Antiretroviral Treatment (HAART): Does success bring further challenges?Ethiopian Journal of Health Development, 2011
- The Global Fight Against HIV/AIDS, Tuberculosis, and MalariaAmerican Journal of Clinical Pathology, 2009
- A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 SuppressionThe Journal of Infectious Diseases, 2006